Bundle Up and Save! Get BOTH the Personal Vision Tracker and the Insight for just $99.99
February 5, 2018
The EyeQue Insight is a valuable self-administered health monitoring tool people ages 6 and up can depend on to provide an accurate measure of visual acuity (VA). Seeing 20/20 with glasses, contact lenses or with our natural eyes is the benchmark of perfect vision. Often, however, we don’t recognize subtle changes in our vision especially if only one eye is affected. Tracking our vision at home with the Insight gives us the ability to discover those subtle vision changes and act upon what we find. Who would benefit from using the Insight?
School vision screenings by a nurse or authorized person are mandatory in the US and vary depending on the State. In California, children are screened during kindergarten or upon first enrollment in a school district, and then again in grades 2, 5 and 8. Children are then referred for an eye exam if their VA is 20/40 or worse at 6 years of age or above, 20/50 or worse for children less than 6 or if there is a difference in VA of 2 lines on the chart. Screening VA every 3 years leaves a wide gap during a period of rapid growth in children. Coupling this with an earlier onset of myopia (nearsightedness) means children’s vision changes could go undetected. Equipping parents with home VA monitoring bridges the gap between school screenings and empowers children’s understanding of the importance of vision.
Chances are that you or someone you know has diabetes. Especially those who are newly diagnosed or whose diabetes is not in good control will tell you that their vision fluctuates. Vision tracking with the Insight allows those with diabetes to assess their VA daily, weekly or monthly to determine how well they are maintaining control of their diabetes. Some who have had laser or injection eye treatment for their diabetes can monitor VA during or after therapy. In-home monitoring between eye appointments can alert those with diabetes to potential changes in the health of their eyes.
Whether you want or have already had refractive surgery it is important to know how well you see over time. Surgery candidates are usually required to have stable vision for at least one year before having refractive surgery to ensure the best long-term outcome. The Insight is useful in monitoring VA changes during this period. Those who are 8-10 years from having refractive surgery may start to notice changes in vision. The Insight is a useful tool to evaluate the significance of these changes.
Certain medications can cause ocular side effects resulting in VA changes. Individuals currently using or having past use of the following medications would benefit from monitoring their vision with the Insight:
Long-term use of glucocorticoids or steroids (i.e. prednisone, betamethasone, budesonide, methylprednisolone, tc.)
Erectile dysfunction medications: Viagra or Cialis
Our baby-boomer population is growing with an estimated 10,000 Boomers turning 65 every day. As a result, cataracts and macular degeneration both age-related eye conditions will also be on the rise. Annual eye exams are important during this time to detect these conditions and provide timely treatment. Between visits, the Insight can alert “boomer” seniors to changes affecting one or both eyes.
If you currently wear glasses or use contact lenses, you can check the validity of your current prescription using the EyeQue Insight. If you are seeing 20/20 (as you should with vision correction), you have the peace of mind that your eyes are helping you perform at your peak, and continue with your annual eye doctor visits. If you do not see 20/20, chances are you have an old prescription that requires renewal, and need an eye exam right away.
Editor, M. S. (2011, October 04). Systemic Drugs with Ocular Side Effects. Retrieved January 30, 2018, from https://www.reviewofophthalmology.com/article/systemic-drugs-with ocular-side-effects
Li, J., Tripathi, R. C., & Tripathi, B. J. (2008). Drug-Induced Ocular Disorders. Drug Safety, 31(2), 127–141. doi:10.2165/00002018-200831020-00003